\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationHybrid
This showcase event is organised by HADEA in collaboration with the Joint Action on increasing Capacity building for National Focal Points (JA NFP4Health), the Horizon Europe Partnership for Transforming Health Care Systems (THCS) the Joint Action on cardiovascular diseases (CVDs) and diabetes (JACARDI) and the Horizon Europe Health National Contact Points (HNN3.0)
The event will focus on synergies by implementation, fostered by the clustering activities promoted by HaDEA. Moreover, the event will also harvest the main lessons learned coming from synergies by design, promoted at call level by the EU funding programmes managed by the Agency.
Within the overarching theme of integrated care, the presentations and discussions will be centred around the prevention of cardiovascular diseases and diabetes as well as the promotion of mental health.
More information and registration on the HNN3.0 website. This 2-day event will be held in Rome and there will be also the possibility to participate online. Deadline for registration is 25/09/24.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
